title: Resveratrol inhibits fibrogenesis and induces apoptosis in keloid fibroblasts.
abstract: Keloids are benign dermal fibrotic tumors arising during the wound healing process. The mechanisms of keloid formation and development still remain unknown, and no effective treatment is available. Resveratrol, a dietary compound, has anticancer properties and, from recent studies, it has been suggested that resveratrol may have an antifibrogenic effect on organs such as the liver and kidney. Based on this idea, we investigated its effect on the regulation of extracellular matrix expression, proliferation, and apoptosis of keloid fibroblasts. Type I collagen, α-smooth muscle actin, and heat shock protein 47 expression decreased in resveratrol-treated keloid fibroblasts in a dose-dependent manner. In addition, resveratrol diminished transforming growth factor-β1 production by keloid fibroblasts. We also demonstrated that it suppressed their proliferation and induced apoptosis of the fibroblasts. Conversely, resveratrol did not decrease type I collagen, α-smooth muscle actin, and heat shock protein 47 mRNA expression in normal skin fibroblasts and barely suppressed cell proliferation. Our data indicate that resveratrol may have an antifibrogenic effect on keloid fibroblasts without any adversely effects on normal skin fibroblasts, suggesting the potential application of resveratrol for the treatment of keloids.
authors.affiliation: Department of Plastic and Reconstructive Surgery, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan. peugeot206ccred@yahoo.co.jp
authors.forename: Kanae
authors.initials: K
authors.lastname: Ikeda
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Torigoe
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Matsumoto
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Fujita
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Sato
authors.forename: Takatoshi
authors.initials: T
authors.lastname: Yotsuyanagi
mesh_terms: D000199:Actins / Q000187:drug effects / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D017209:Apoptosis / Q000187:drug effects*; D002478:Cells, Cultured; D024042:Collagen Type I / Q000187:drug effects / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005260:Female; D005347:Fibroblasts / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D005355:Fibrosis / Q000378:metabolism; D050958:HSP47 Heat-Shock Proteins / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007627:Keloid / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology*; D053773:Transforming Growth Factor beta1 / Q000187:drug effects / Q000378:metabolism; D014945:Wound Healing / Q000187:drug effects
chemical_list: C541116:ACTA2 protein, human; D000199:Actins; D024042:Collagen Type I; D004791:Enzyme Inhibitors; D050958:HSP47 Heat-Shock Proteins; C494660:SERPINH1 protein, human; D013267:Stilbenes; C508960:TGFB1 protein, human; D053773:Transforming Growth Factor beta1; D000077185:Resveratrol